← Evidence map

ReviewFrontiers in oncology2022

Caspase-8: Friend or Foe in Bortezomib/Lenalidomide-Based Therapy for Myeloma.

Liang ZhouPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35321428